187 related articles for article (PubMed ID: 31586008)
21. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
[TBL] [Abstract][Full Text] [Related]
22. PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
Zhang T; Das SK; Fels DR; Hansen KS; Wong TZ; Dewhirst MW; Vlahovic G
AJR Am J Roentgenol; 2013 Nov; 201(5):W698-706. PubMed ID: 24147499
[TBL] [Abstract][Full Text] [Related]
23. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269
[TBL] [Abstract][Full Text] [Related]
24. Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.
Obata A; Yoshimi E; Waki A; Lewis JS; Oyama N; Welch MJ; Saji H; Yonekura Y; Fujibayashi Y
Ann Nucl Med; 2001 Dec; 15(6):499-504. PubMed ID: 11831397
[TBL] [Abstract][Full Text] [Related]
25. (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
Yoshii Y; Furukawa T; Matsumoto H; Yoshimoto M; Kiyono Y; Zhang MR; Fujibayashi Y; Saga T
Cancer Lett; 2016 Jun; 376(1):74-82. PubMed ID: 26996296
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.
Carlin S; Zhang H; Reese M; Ramos NN; Chen Q; Ricketts SA
J Nucl Med; 2014 Mar; 55(3):515-21. PubMed ID: 24491409
[TBL] [Abstract][Full Text] [Related]
27. Paired 18F-Fluorodeoxyglucose (18F-FDG), and 64Cu-Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) (64Cu-ATSM) PET Scans in Dogs with Spontaneous Tumors and Evaluation for Hypoxia-Directed Therapy.
Maitz CA; Tate D; Bechtel S; Lunceford J; Henry C; Flesner B; Collins A; Varterasian M; Tung D; Zhang L; Saha S; Bryan JN
Radiat Res; 2022 Mar; 197(3):253-260. PubMed ID: 34855934
[TBL] [Abstract][Full Text] [Related]
28. Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxia.
McCall KC; Humm JL; Bartlett R; Reese M; Carlin S
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e393-9. PubMed ID: 22727887
[TBL] [Abstract][Full Text] [Related]
29. Retention of the radiotracers 64Cu-ATSM and 64Cu-PTSM in human and murine tumors is influenced by MDR1 protein expression.
Liu J; Hajibeigi A; Ren G; Lin M; Siyambalapitiyage W; Liu Z; Simpson E; Parkey RW; Sun X; Oz OK
J Nucl Med; 2009 Aug; 50(8):1332-9. PubMed ID: 19617332
[TBL] [Abstract][Full Text] [Related]
30. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
Fujibayashi Y; Taniuchi H; Yonekura Y; Ohtani H; Konishi J; Yokoyama A
J Nucl Med; 1997 Jul; 38(7):1155-60. PubMed ID: 9225812
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.
Ballegeer EA; Madrill NJ; Berger KL; Agnew DW; McNiel EA
BMC Cancer; 2013 Apr; 13():218. PubMed ID: 23631652
[TBL] [Abstract][Full Text] [Related]
32. Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.
Tateishi K; Tateishi U; Sato M; Yamanaka S; Kanno H; Murata H; Inoue T; Kawahara N
AJNR Am J Neuroradiol; 2013 Jan; 34(1):92-9. PubMed ID: 22700754
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer.
Kinoshita T; Fujii H; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H
Lung Cancer; 2016 Jan; 91():56-66. PubMed ID: 26711935
[TBL] [Abstract][Full Text] [Related]
34. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
Myerson RJ; Singh AK; Bigott HM; Cha B; Engelbach JA; Kim J; Lamoreaux WT; Moros E; Novak P; Sharp TL; Straube W; Welch MJ; Xu M
Int J Hyperthermia; 2006 Mar; 22(2):93-115. PubMed ID: 16754595
[TBL] [Abstract][Full Text] [Related]
35. Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.
Bradshaw TJ; Yip S; Jallow N; Forrest LJ; Jeraj R
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):399-405. PubMed ID: 24685446
[TBL] [Abstract][Full Text] [Related]
36. Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM.
Dearling JL; Packard AB
Nucl Med Biol; 2010 Apr; 37(3):237-43. PubMed ID: 20346863
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
Lohith TG; Kudo T; Demura Y; Umeda Y; Kiyono Y; Fujibayashi Y; Okazawa H
J Nucl Med; 2009 Dec; 50(12):1948-53. PubMed ID: 19910425
[TBL] [Abstract][Full Text] [Related]
38. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
39. Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
Oh M; Tanaka T; Kobayashi M; Furukawa T; Mori T; Kudo T; Fujieda S; Fujibayashi Y
Nucl Med Biol; 2009 May; 36(4):419-26. PubMed ID: 19423010
[TBL] [Abstract][Full Text] [Related]
40. Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.
Burgman P; O'Donoghue JA; Lewis JS; Welch MJ; Humm JL; Ling CC
Nucl Med Biol; 2005 Aug; 32(6):623-30. PubMed ID: 16026709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
